Prescribing of venlafaxine and dosulepin in primary care.
McAllister-Williams
R Hamish
RH
Foran
Karin
K
Forrest
Steven
S
Ingram
Graham
G
McMahon
Lindsay
L
Taylor
Michelle
M
Rajwal
Madhuri S
MS
Cornwall
Peter L
PL
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000627:therapeutic use*; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004308:Dothiepin / Q000009:adverse effects* / Q000627:therapeutic use*; D017408:Guidelines as Topic; D006801:Humans; D011320:Primary Health Care; D013405:Suicide / Q000523:psychology; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride; D004308:Dothiepin